(“Ananda” or the “Company”)
Result of General Meeting and Appointment of a Director
The Directors of
Accordingly, the Acquisition has been completed. The subscription by
Concert Party Interests
On completion of the Subscription, URA will be interested in 88,888,888 Ordinary Shares representing 21.26 per cent of the Company’s issued share capital as enlarged by the Subscription and the
The table below illustrates the maximum potential interest of the
Concert Party Current Founder Subscription Contingent Exercise of Maximum Maximum Member holding of Warrants Warrants Consideration Options interest in percentage Ordinary Shares Ordinary interest in Shares Shares voting rights following following exercise of exercise of the Founder the Founder Warrants, Warrants, exercise of exercise of the the Subscription Subscription Warrants, the Warrants, the issue of the issue of the Contingent Contingent Consideration Consideration Shares and Shares and exercise of exercise of Options Options Charles Morgan 22,500,000 23,041,666 - 100,000,000 - 145,541,666 19.06% Melissa Sturgess* 46,612,222 23,041,666 - 100,000,000 - 169,653,888 22.22% Jeremy Sturgess-Smith 1,700,000 - - - 10,451,389 12,151,389 1.59% Peter Redmond 5,000,000 - - - - 5,000,000 0.65% Alex Gostevskikh - - - - - - - Michael Langoulant 3,000,000 - - - - 3,000,000 0.39% URA 88,888,888 - 88,888,888 - - 177,777,776 23.29% TOTAL HOLDING OF CONCERT PARTY 167,701,110 46,083,332 88,888,888 200,000,000 10,451,389 513,124,719 67.21% TOTAL SHARES IN ISSUE 418,055,554 464,138,886 553,027,774 753,027,774 763,479,163 763,479,163
*of the 46,612,222 Ordinary Shares held by
On completion of the Subscription, the Company’s issued share capital will comprise 418,055,554 Ordinary Shares. The figure of 418,055,554 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority’s Disclosure and Transparency Rules.
Words and expressions defined in the Circular have the same meaning in this announcement. A copy of the full text of the Circular is available at www.anandadevelopments.com.
The Directors of the Company accept responsibility for the contents of this announcement.
ANANDA DEVELOPMENTS PLC+44 (0)7392 696 517 email@example.com Chief Executive Officer Melissa SturgessInvestor Relations Jeremy Sturgess-SmithPETERHOUSE CAPITAL LIMTED +44 (0)20 7469 0930 Corporate Finance Mark Anwyl Fungai NdoroCorporate Broking Lucy Williams Duncan Vasey
Ananda Developments invests in the developing market for medical or therapeutic Cannabis derivatives, or related products, including but not limited to nutraceuticals, dietary supplements and cosmetic products which contain Cannabis or hemp derived cannabinoids. The Directors believe that this market is growing due to an increasing number of states in the
A copy of the Company’s Admission Document is available at www.anandadevelopments.com.
Ananda’s investment strategy is to invest in companies, projects or products that are progressing medical or therapeutic Cannabis research and development, or seeking to produce or cultivate Cannabis in any jurisdiction in which it is legal to do so, or are developing or have already developed, products that contain Cannabis derived cannabinoids and require funding to progress work plans or commercialise products.
Market Abuse Regulation (MAR) Disclosure
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via a